What Happened?
Toronto, ON-based Notch-Therapeutics Appointed David Main as President and Chief Executive Officer
About the Company
Notch is an immune cell therapy company developing a next-generation pipeline of off-the-shelf, universally compatible, genetically tailored T cell therapeutics derived from renewable stem cell sources for the treatment of high-impact diseases, with an initial focus on cancer.
About the Person
David Main is President and Chief Executive Officer at Notch Therapeutics. Previously, David held various senior HR leadership roles in the industry.
Info Source
News
Short Profile